Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients

Wen Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Aiping Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College)
Clinical Cancer Research
March 11, 2022
Cited by 56


Related Papers